关于消毒副产品与癌症之间的联系的全球研究趋势:绘制知识景观和可视化分析
Shaher Zyoud1,2, Sa'ed H Zyoud3,4
1Department of Building Engineering & Environment, Palestine Technical University (Kadoorie), Tulkarem, Palestine.
Journal of water and health
|September 30, 2025
概括
消毒副产品 (DBPs) 引发了癌症的担忧. 这份图书统计分析绘制了DBP和癌症的全球研究,确定了关键研究领域,并敦促更新水处理标准.
科学领域:
- 环境科学 环境科学
- 毒理学 毒理学 毒理学
- 公共卫生 公共卫生
背景情况:
- 消毒确保了水的安全,但产生了消毒副产品 (DBPs).
- 越来越多的证据将DBP与潜在的致癌效应联系在一起.
- 关于许多DBP的形成,毒性和流行情况的研究有限.
研究的目的:
- 对有关消毒副产品和癌症的文献进行文献计量分析.
- 阐明当前的研究环境,并确定未来的研究重点.
- 为有关饮用水和废水处理标准的政策提供信息.
主要方法:
- 从1976年至2023年间对1045篇出版物的图书统计分析来源于Scopus.
- 研究集群和热门话题的识别和分类.
- 分析出版趋势和主要贡献国.
主要成果:
- 美国,中国和加拿大是DBP癌症研究的主要贡献者.
- 关键的研究集群包括DBP形成机制,相关的癌症类型和毒性评估.
- 研究涵盖了从消毒剂处理新出现的污染物,基因毒性和毒性的DBP形成.
结论:
- 跨学科和国际研究合作至关重要.
- 目前的饮用水和废水处理标准需要修订,以包括DBP限制.
- 需要进一步的研究,以充分了解DBP风险和缓解策略.
相关概念视频
Types of Toxins
3.2K
Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
3.2K
Cancer Prevention
7.7K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
7.7K
Cancer Survival Analysis
648
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
648
Mutagenicity and Carcinogenicity
1.9K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.9K


